Lobe Sciences Ltd.
LOBEF
$0.0225
-$0.0003-1.32%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -40.65% | 7.49% | 50.89% | 63.44% | 67.76% |
| Total Depreciation and Amortization | -20.42% | 91.41% | 267.73% | 693.48% | 495.45% |
| Total Amortization of Deferred Charges | -- | -- | -100.88% | -43.75% | -- |
| Total Other Non-Cash Items | 564.51% | 78.96% | -92.94% | -90.00% | -93.61% |
| Change in Net Operating Assets | -39.51% | -13.05% | 7.05% | 202.91% | 367.37% |
| Cash from Operations | 22.56% | 73.53% | 36.18% | 92.09% | 75.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 67.21% | 67.21% | 0.24% | -75.19% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -99.20% | -99.38% | -98.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 99.93% |
| Cash from Financing | 53.31% | -41.41% | -78.56% | -96.65% | -88.75% |
| Foreign Exchange rate Adjustments | 944.44% | -380.00% | -161.54% | -683.33% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.06% | 112.24% | -906.86% | 81.72% | 59.90% |